P09.01 Adapting immune cells to the hypoglycemic tumor microenvironment by solute carrier 2a1 (Slc2a1/GLUT1) overexpression von Kirmaier, ME, Cadilha, BL, Hadzic, A, Schmitz, W, Benmebarek, MR, Briukhovetska, D, Michaelides, S, Buschinger, V, Tast, B, Bönigk, CH, Oganesian, S, Vona, L, Tischmacher, A, Heissmeyer, V, Vaeth, M, Buchholz, VR, Eilers, M, von Bergwelt-Baildon, M, Subklewe, M, Kobold, S, Theurich, S

Volltext

10.01 Effective solid tumor therapy through enhanced recruitment and immune suppression shielded T cells von Cadilha, B L, Benmebarek, M R, Dorman, K, Oner, A, Lorenzini, T, Obeck, H, Stoiber, S, Huynh, D, Märkl, F, Seifert, M, Manske, K, Endres, S, Kobold, S

Volltext

P06.03 C-C chemokine receptor 8 tumor-directed recruitment enables CAR T cells to reject solid tumors von Cadilha, B L, Dorman, K, Huynh, D, Lorenzini, T, Vänttinen, M, M-R Benmebarek, Stoiber, S, Suárez-Gosálvez, J, Endres, S, Kobold, S

Volltext

P06.05 IDO1-deleted CAR T cells show improved therapeutic efficacy in murine pancreatic cancer models von Senz, A M, Metzger, P, Rubens, R K, Cadilha, B, Kirmaier, M, Lesch, S, Benmebarek, M R, Theurich, S, Murray, P, Endres, S, Kobold, S, König, L M, Duewell, P, Schnurr, M

Volltext